Asthma is a chronic (long-term) disease that causes inflammation and swelling of your airways. Nasal polyps are soft tissue growths on the lining inside the nose and sinuses. While they seem very different, they are actually related.

What Do Nasal Polyps and Asthma Have in Common?

Both asthma and nasal polyps are caused by something called type 2 inflammation. Type 2 inflammation is a type of immune response. This type of response happens when your body senses an intruder like an infection or allergens. But sometimes, your immune system has a type 2 response when there is no intruder. This ends up causing damage to the body itself.

If you have a condition caused by type 2 inflammation – such as asthma – you have a good chance of having another type 2 condition. This is how nasal polyps and asthma are connected. If you have asthma, you have a greater chance of having nasal polyps.

What Should I Do If I Think I Have Nasal Polyps?

If you think you have nasal polyps, an allergist or ear, nose, and throat specialist (ENT) can make a diagnosis. They can help you come up with a treatment plan to help you manage your nasal polyps.

You will likely see a team of doctors if you have nasal polyps, especially if you also have asthma. They can include:

• Primary care physician (PCP)
• Ear, nose, and throat (ENT) specialist
• Allergist/immunologist
• Sinus surgeon (ENT or neurosurgeon)
  
  

Keeping your nasal polyps and asthma under control is important for your quality of life and health. This may include managing possible allergies too. If you do not get treatment for nasal polyps, they can cause long-term problems in your nose and sinuses.

Where Can I Find Nasal Polyps Resources?

Nasal polyps are also known as chronic rhinosinusitis with nasal polyps (CRSwNP) and nasal polyp syndrome. The Asthma and Allergy Foundation of America (AAFA) offers resources on nasal polyps to help you learn more about signs and symptoms, management, and treatment options.

• AAFA offers free educational programs for people with nasal polyps and their caregivers. Watch nasal polyps webinars on demand.
  
  
• AAFA’s Life with Nasal Polyps report identifies unmet needs and areas of opportunity for improving nasal polyps care.
  
  
• Want to learn more about nasal polyps? See AAFA’s A Guide to Nasal Polyps.

Print, download, and share

Educational content created independently by AAFA with support from Sanofi and Regeneron.

Medical Review: adapted from the webpages “What is Type 2 Inflammation?” reviewed June 2023 and “Nasal Polyps,” reviewed July 2024 by John James, MD

References
1. Khan, A. H., Gouia, I., Kamat, S., Johnson, R., Small, M., & Siddall, J. (2023a). Prevalence and severity distribution of type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis. Lung, 201(1), 57–63. https://doi.org/10.1007/s00408-023-00603-z

Class 2 Device Recall NasoGel Spray

For Immediate Release

February 05, 2025

Contact Information

Mr. Srikanth Pai
707-525-3784

Company Announcement

On 12/28/2024, the firm sent an "URGENT: MEDICAL DEVICE RECALL" Letter to customers informing them that firm is conduct a voluntary recall due to a microbial failure found during routine stability testing and the receipt of complaints (11 reports) related to the products unpleasant odor. Through investigation, this has led to the recall of 3 lots. We started shipping these lots in April 2024.

Customer are instructed to:
Immediately examine their inventory and quarantine products subject to recall and destroy the identified lots. In addition, if the affected products have been further distributed, please identify the consumers and notify them at once of this product recall. A copy of this recall notification letter may enhance your notification to your consumers.

The firm will provide customers with a refund or product replacement at no cost.

Please send us the proof of destruction via email to quality@neilmed.com.

For any questions, contact Dinesh Patel. M F, 8:00 am - 5:00 pm PST, (707) 889-4625.

On or about 02/06/2025, the firm added a Recall Statement to it company website https://shop.neilmed.com/products/nasogel-spray that reads "Recall Notice: NeilMed is voluntarily recalling NasoGel Spray lots NGS751, NGS757, and NGS762 distributed in 2024 due to potential contamination, which may lead to symptoms similar to the flu. If your product is affected, please email questions@neilmed.com and put NGS-PA in the subject for further instructions.

NasoGel Spray

• UDI-DI/UPC code: 00705928045309
  SKU / Lot Numbers:
  
  • GSP30-2R-48-ENU-USL / NGS751
  • GSP30-0R-96-ENU-USL / NGS757 and NGS762
  • GSP30-ARA-INTL / NGS762
  • GSP30-SWE-INTL / NGS754
  • GSP30-ENG-INT / NGS755
  • GSP30-MAL-INTL / NGS756
  • GSP30-SPA-INT / NGS760 and NGS761

NasoGel Spray is a saline-based gel formula that can be sprayed to moisturize and lubricate dry and irritated anterior or front of nasal passages caused by dry climate and indoor heat.

Join the Asthma and Allergy Foundation of America (AAFA) in celebrating Black History Month.

In February, we take the time to reflect and celebrate the achievements of Black people in the United States throughout this nation’s history. Our Black communities and leadership across this nation continue to innovate, advocate for, and lead major efforts in improving the health of people living with asthma, allergies, and allergic conditions.

While honoring the progress made, AAFA continues to work toward better health outcomes for our Black communities facing health inequities in the United States.

The stark reality is that nearly 28 million people in the U.S. have asthma. The burden still falls disproportionately on Black people in the U.S. – along with Hispanic and Indigenous people. These populations experience the highest asthma rates, deaths, and hospitalizations.

What Can Be Done?

Supporting AAFA’s mission helps support local initiatives – like our Health Equity Advancement and Leadership (HEAL) program – empower local communities to improve their health. HEAL provides asthma management education, home assessments to reduce asthma and allergy triggers, helps make connections to specialists, and more.

Since HEAL’s inception, over 250 people now manage their asthma better in communities like Detroit, St. Louis, and Los Angeles. This means fewer emergency department visits, better sleep, and more opportunities to enjoy school and attend work. Most of the people in these local programs identify as Black women.

Resources

AAFA works closely with program advisors from the Black community who also live with asthma and allergies. In 2024, AAFA’s Black Women’s Asthma Alliance created a private Facebook group for Black women who live with asthma and their caregivers. This group provides a supportive and educational community to ask questions, learn more about asthma care, and meet others. Join the Facebook group: aafa.org/joinbwaa  

Join Us

Join AAFA and stay connected for opportunities to share your patient and caregiver voice. AAFA provides educational resources, local and national advocacy opportunities, research updates and opportunities, and community support.

Why You Need to Rinse and Spit

Did you know there is a connection between oral health and asthma?

When you use an asthma inhaler that has corticosteroids [CORE-te-coh-STAIR-oids] in it, the medicine can stick to the inside of your mouth. When the medicine stays in your mouth, it may cause problems with your teeth, gums, tongue, and cheeks.

Using corticosteroid inhalers can lead to:

• Thrush – a fungal infection on your tongue or cheeks
• Dry mouth
• Gum irritation and swelling
• Cavities (dental caries)
  
  

Examples of inhalers that have corticosteroids include:

• Advair Diskus® and Wixela Inhub® (fluticasone/salmeterol)
• AirDuo® (fluticasone/salmeterol)
• ArmonAir™ Digihaler® (fluticasone propionate)
• ARNUITY® ELLIPTA® (fluticasone furoate)
• Asmanex® Twisthaler® (mometasone)
• Dulera® (mometasone/formoterol) HFA
• Fluticasone propionate (generic version of Flovent)
• Pulmicort® Flexhaler® (budesonide)
• QVAR® RediHaler™ (beclomethasone dipropionate)
• Symbicort® (budesonide/formoterol) HFA
  
  

If you aren’t sure if your inhaler has a corticosteroid in it, contact your doctor.

The good news is you can keep your mouth healthy! After you use your asthma inhaler, rinse your mouth well with water and spit it out or brush your teeth. If you have a child with asthma, they may be more likely to get cavities, so it is important to teach them to rinse and spit after using their asthma inhaler.

If you use a metered dose inhaler, use a spacer. It can help reduce the amount of medicine in your mouth and throat.

Don’t forget to also floss, brush your teeth 2 times a day, and limit sugary foods and drinks. See your dentist 2 times a year so they can make sure your mouth and teeth stay healthy.

Reducing exposure to triggers and allergens is a critical part of controlling asthma and allergy symptoms. And many products promise to help improve indoor air quality and reduce your exposure to asthma and allergy triggers. But some products make false or exaggerated claims. This makes it hard for people to know the best products to use.

AAFA joined with Allergy Standards Limited (ASL) to create the Asthma & Allergy Friendly® Certification Program. We independently test household products against strict scientific standards. If products pass our tests, they earn the Asthma & Allergy Friendly® Certification Mark. When you see this mark, you know the product is proven to be better suited for people with asthma and allergies.

A New Asthma & Allergy Friendly® Certification Mark

The Asthma & Allergy Friendly® Certification Program has a new mark! The new Certification Mark is now easier to identify on product packaging and online platforms. This new design will help you quickly find products that meet our strict standards.

The design features a lung shape to represent a connection to breathing and well-being. For the more than 100 million people in the United States with asthma and/or allergies, good respiratory health is critical.

You’ll still see the old mark on certified products until the new mark is fully rolled out.

How Do I Find Asthma & Allergy Friendly® Certified Products?

There are more than 200 certified products in the United States. Visit the Asthma & Allergy Friendly® Certification Program website to find a list of certified products, including:

• Air cleaners including portable air purifiers and whole home air care systems
• Air filters
• Bedding including pillows, sheets, and pillow and mattress covers
• Cleaning products
• Flooring
• Insulation
• Laundry appliances and detergents
• Paint
• Vacuum cleaners
  

Remember to look for the Asthma & Allergy Friendly® Certification Mark when choosing products. These products are proven to reduce your exposure to indoor asthma and allergy triggers.

Asthma and Allergy Foundation of America Reaffirms Commitment to Protect Vulnerable Communities

On behalf of over 100 million people in the United States with asthma and allergic diseases, the Asthma and Allergy Foundation of America (AAFA) is carefully monitoring and evaluating policy transitions that may affect our community’s health.

Asthma and allergies are chronic and potentially life-threatening conditions affecting almost every household: nearly 1 in 3 adults and more than 1 in 4 U.S. children have seasonal allergy, eczema, or food allergy. Asthma is the leading chronic disease in children (aside from dental cavities). In 2013, researchers estimated that asthma-related costs to society totaled $82 billion per year, a number sure to be higher today.

AAFA, founded in 1953, is the leading patient organization for people with asthma and allergies, and the oldest asthma and allergy patient group in the world.  With a track record spanning over 70 years and 13 presidential administrations, our organization is the trusted voice for the asthma and allergy community.  While each administration’s priorities differ, the priority of AAFA remains steady. Our mission is to save lives and reduce the burden of disease for people with asthma and allergies.

When new federal or state policies are proposed or enacted, we carefully analyze for potential impacts on our community. Sometimes, the immediate or long-term impacts are unknown, and so continued monitoring is required. AAFA pledges to act with integrity and provide the best information available.

AAFA’s work is critical to protect the health of children, adults, and seniors with respiratory or allergic diseases. Actions such as rollbacks of clean air protections or climate change mitigations, reduced federal funding and staffing for the HHS (FDA, NIH, CDC, CMS, OCR), elimination of programs that address health disparities, or efforts to reduce health care coverage all threaten vital safety nets and disproportionately affect our most vulnerable communities.

“AAFA provides a lifeline of support to help people with asthma and allergies,” states AAFA President and CEO Kenneth Mendez. “Our commitment to our community remains strong. As always, we endeavor to earn and keep the trust of our community and be an ally in their health.”

AAFA amplifies the voices of patients and caregivers from our community. We aim to empower people with asthma and allergies to champion policies that will improve their lives. Our membership in coalitions and alliances helps us build even stronger support for our community. AAFA’s commitment is unwavering: We will continue our fierce advocacy for policies and programs that protect the health of our community.

AAFA provides evidence-based information on a range of topics including asthma, seasonal allergies, food allergies, eczema, nasal polyps, eosinophilic esophagitis, and other allergic conditions. For more information, visit aafa.org and kidswithfoodallergies.org, or call 800-7-ASTHMA (800-727-8462).